Javascript must be enabled to continue!
Abstract P6-02-01: Meta-Analysis of Ductal Carcinoma In Situ (DCIS) on Core Needle Biopsy — Underestimation and Predictors of Invasion
View through CrossRef
Abstract
Background: A diagnosis of ductal carcinoma in situ (DCIS) on core needle biopsy (CNB) may represent an underestimate (or understaging) of invasive breast cancer (IBC). This is identified on excision histology in 4%-35% of CNB diagnoses of DCIS. It is of clinical significance as it may prevent informed discussion about management options for IBC and may mean that more than one surgical procedure is required. We systematically review the literature on CNB to report pooled estimates for underestimation of IBC following CNB diagnosis of DCIS and identify preoperative predictors of invasion.
Methods: Studies were identified by searching MEDLINE and were evaluated against predetermined inclusion criteria: data were extracted independently by 2 authors. We calculated study-specific proportions for DCIS underestimates. Using meta-regression (random effects logistic models) we investigated the association between study-level preoperative variables and understaged IBC.
Results: 47 studies met eligibility criteria reporting 6,213 cases of DCIS on CNB with excision histology as the reference standard.
Table 1: Pooled underestimation rates for
There were 1,482 underestimates (DCIS on CNB and IBC on excision); pooled estimate 25.9%(95% CI 22.2, 29.9). Preoperative variables associated with underestimation included ultrasound-guidance (vs stereotaxis), 14Gautomated (vs 11GVAB), high grade CNB lesion (vs nonhigh grade), size >20mm, BIRADS 4/5 (vs BIRADS3), mammographic mass (vs calc only) and palpability.
Conclusion: Using available evidence we estimate that around 26% of CNB DCIS diagnoses represent understaged IBC. We identified preoperative variables associated with higher risk of understaging. This information can be used for preoperative discussion of management options, including possible sentinel node biopsy at the time of excision.
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P6-02-01.
American Association for Cancer Research (AACR)
Title: Abstract P6-02-01: Meta-Analysis of Ductal Carcinoma In Situ (DCIS) on Core Needle Biopsy — Underestimation and Predictors of Invasion
Description:
Abstract
Background: A diagnosis of ductal carcinoma in situ (DCIS) on core needle biopsy (CNB) may represent an underestimate (or understaging) of invasive breast cancer (IBC).
This is identified on excision histology in 4%-35% of CNB diagnoses of DCIS.
It is of clinical significance as it may prevent informed discussion about management options for IBC and may mean that more than one surgical procedure is required.
We systematically review the literature on CNB to report pooled estimates for underestimation of IBC following CNB diagnosis of DCIS and identify preoperative predictors of invasion.
Methods: Studies were identified by searching MEDLINE and were evaluated against predetermined inclusion criteria: data were extracted independently by 2 authors.
We calculated study-specific proportions for DCIS underestimates.
Using meta-regression (random effects logistic models) we investigated the association between study-level preoperative variables and understaged IBC.
Results: 47 studies met eligibility criteria reporting 6,213 cases of DCIS on CNB with excision histology as the reference standard.
Table 1: Pooled underestimation rates for
There were 1,482 underestimates (DCIS on CNB and IBC on excision); pooled estimate 25.
9%(95% CI 22.
2, 29.
9).
Preoperative variables associated with underestimation included ultrasound-guidance (vs stereotaxis), 14Gautomated (vs 11GVAB), high grade CNB lesion (vs nonhigh grade), size >20mm, BIRADS 4/5 (vs BIRADS3), mammographic mass (vs calc only) and palpability.
Conclusion: Using available evidence we estimate that around 26% of CNB DCIS diagnoses represent understaged IBC.
We identified preoperative variables associated with higher risk of understaging.
This information can be used for preoperative discussion of management options, including possible sentinel node biopsy at the time of excision.
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P6-02-01.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
Abstract
Background
Breast ductal cancer in situ (DCIS) can recur or progress to invasive ductal cancer (IDC), and the interim stage include DCIS...
Breast Ductal Carcinoma In Situ with Microinvasion: Clinicopathological Characteristics, Prognosis and Role of Surgery in Treatment
Breast Ductal Carcinoma In Situ with Microinvasion: Clinicopathological Characteristics, Prognosis and Role of Surgery in Treatment
Background: Advances in screening have led to almost half of the reduction in breast cancer mortality. Precocious diagnosis increasingly needs clinicians to better treat early brea...
BS18
DCIS AND TREATMENT
BS18
DCIS AND TREATMENT
Ductal carcinoma in situ now represents 30% of all screen detected breast cancers. Breast conserving surgery for ductal carcinoma in situ is now established although the extent of ...
Underestimation of malignancy of breast core‐needle biopsy
Underestimation of malignancy of breast core‐needle biopsy
AbstractBACKGROUND:A review of the literature indicated variable underestimation rates for breast core‐needle biopsy (CNB) based on generally small series. In this article, the aut...
Abstract 1583: The tumor immune microenvironment in early breast cancer progression
Abstract 1583: The tumor immune microenvironment in early breast cancer progression
Abstract
Ductal carcinoma in situ (DCIS), comprising 20% of all breast cancer diagnoses, is a neoplastic proliferation of epithelial cells confined to the luminal co...
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract
Introduction
Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...

